Table 1 Demographic and clinical characteristics of study participants.
Demographic characteristics | n (%) |
|---|---|
Black race | 9 (100) |
Median age in years (range) | 18 (17–21) |
Clinical and laboratory findings | n (%) |
No STI or bacterial vaginosis | 6 (66.7) |
Chlamydia trachomatis (PCR positive) | 1 (11.1) |
Neisseria gonorrhoeae (PCR positive) | 0 (0) |
Trichomonas vaginalis (PCR positive) | 0 (0) |
Mycoplasma genitalium (PCR positive) | 0 (0) |
HSV-2 IgG | 0 (0) |
HSV (PCR positive) | 0 (0) |
Treponema pallidum (RPR > 1:4, TPHA positive) | 0 (0) |
Bacterial vaginosis (Nugent score ≥ 7) | 2 (22.2) |
Intermediate flora (Nugent score 4–6) | 0 (0) |
Yeast cells | 1 (11.1) |
Any STI or bacterial vaginosis | 3 (33.3) |
Abnormal vaginal discharge | 1 (11.1) |
Median vaginal swab pH (range) | 4.7 (4.1–5.3) |
Median soft-cup pH (range) | 4.3 (3.6–5.6) |
Contraception | |
*Petogen | 2 (22.2) |
*Nur-Isterate | 7 (77.8) |
